Page 19 of 20
PA32.1-7 | Bone & Soft Tissue — Case Study
CLINICAL SCENARIO
This assignment presents a real-world clinico-pathological scenario involving a primary bone tumour in an adolescent. You will apply your knowledge of bone tumour biology, radiologic-pathologic correlation, and pathogenesis to construct a structured analysis that mirrors how a pathologist thinks through a case.
Working through this case develops the core competencies expected of a Year-2 MBBS student in Pathology (PA32.1-PA32.7): recognising the hallmark radiologic and histological features of bone tumours, understanding the molecular basis of neoplastic bone formation, formulating a reasoned differential diagnosis, and appreciating the prognostic implications of each diagnostic step. Peer review of a classmate's submission sharpens your ability to critique pathological reasoning -- a skill central to clinical practice.
Instructions
Read the clinical vignette below carefully before you begin writing.
CLINICAL VIGNETTE
Kartik, a 15-year-old male, presents to the orthopaedic outpatient department with a 6-week history of progressively worsening pain around the right knee, worse at night, associated with a visible, firm, non-tender swelling over the distal femur. There is no history of trauma. His parents noticed the swelling two weeks after the pain began. General examination is unremarkable. Local examination reveals a hard, non-pulsatile mass (approximately 7 x 5 cm) over the distal femur, with overlying skin warmth but no redness. Serum alkaline phosphatase is markedly elevated (540 U/L; normal 40-130 U/L). Plain radiograph of the right knee shows an aggressive lytic-sclerotic lesion in the metaphysis of the distal femur with cortical destruction, a Codman triangle at the proximal margin, and a perpendicular periosteal reaction (sunburst pattern). Chest X-ray is clear. MRI confirms intramedullary tumour extension with a soft tissue component. An open biopsy is scheduled.
INSTRUCTIONS
- Work through ALL scaffolding sections in order. Each section has a guiding prompt -- answer the prompt fully within that section.
- Integrate the clinical, radiologic, and (anticipated) histological data at each step; do not treat them as independent silos.
- Use appropriate anatomical and pathological terminology throughout.
- Your submission should be 600-900 words (excluding headings and references). Concise, precise answers score higher than verbose ones.
- Include a minimum of two referenced sources (Harrison's, Robbins, or peer-reviewed journals; Vancouver style). References do not count toward the word limit.
- Submit your completed write-up via Canvas by the stated deadline. After submission you will be assigned two peer submissions to review using the provided rubric. Complete both peer reviews before the peer-review deadline -- incomplete peer review attracts a 5-point deduction from your own score.
- Be specific: where the prompt asks for a morphological feature, name the feature (e.g., 'osteoid production by malignant spindle cells') rather than using generic descriptors.
Length: 600-900 words (excluding headings, bullet lists used for enumerations, and references)
What to Submit
1. Clinical Summary & Preliminary Differential Diagnosis
Summarise the key clinical and biochemical findings in 3-4 sentences. Then list THREE differential diagnoses for an aggressive metaphyseal bone lesion in an adolescent, ranked from most to least likely. For each differential, state ONE clinical or radiologic feature that supports it and ONE that argues against it. Explain why you rank osteosarcoma highest.
2. Radiologic-Pathologic Correlation
Explain the pathological basis of EACH of the following radiologic signs seen in this case: (a) the Codman triangle, (b) the sunburst (perpendicular periosteal) pattern, and (c) the mixed lytic-sclerotic appearance of the lesion. For each sign, describe the underlying tissue process that produces the radiologic appearance. What does the MRI soft-tissue component tell you about tumour behaviour?
3. Expected Gross & Microscopic Pathology
Describe what the pathologist would expect to see on: (a) gross examination of the resected distal femur (cut surface, colour, texture, extent, cortical involvement), and (b) haematoxylin & eosin (H&E) microscopy (cell morphology, matrix production, mitoses, vascular invasion, any zonal pattern). Name the histological subtype most likely in this case and state its defining microscopic criterion. Mention one immunohistochemical or special stain that aids diagnosis and what it would show.
4. Pathogenesis & Molecular Basis
Outline the current understanding of osteosarcoma pathogenesis. Your answer should address: (i) the cell of origin and why the metaphysis of long bones in adolescents is the characteristic site, (ii) the role of tumour-suppressor gene loss (name at least two genes with their chromosomal loci), (iii) how loss of these genes disrupts the cell cycle, and (iv) the significance of the markedly elevated serum alkaline phosphatase both diagnostically and as a marker of tumour activity.
5. Laboratory Investigations & Staging
List the investigations you would request BEYOND the plain radiograph and MRI already obtained. For each investigation state the specific finding you are looking for and its clinical significance. Include at least: one imaging modality for systemic staging, one serum marker, and one tissue-based investigation. Briefly describe the Enneking (MSTS) surgical staging system and assign this tumour to a stage, justifying your assignment.
6. Prognosis & Clinico-Pathological Correlates
Discuss the prognostic factors in osteosarcoma. Your answer should address: (a) histological response to neoadjuvant chemotherapy (Huvos grading -- define Grade III and Grade IV responses and their 5-year survival implications), (b) the significance of the chest X-ray being clear at presentation, and (c) TWO adverse histological features (other than metastasis) that would worsen the prognosis if found at definitive resection. Conclude with one sentence on the role of the pathologist in the multidisciplinary team for this patient.
Grading Rubric — Bone & Soft Tissue Case Study Rubric
| Criterion | Points | Full-marks descriptor |
|---|---|---|
| Differential Diagnosis & Clinical Reasoning -- Assesses whether the student can construct a prioritised, evidence-linked differential for an aggressive metaphyseal bone lesion, demonstrating understanding of PA32.1 (bone tumours) and PA32.4 (Paget disease excluded systematically) | 5 pts | Three appropriate differentials ranked correctly with accurate supporting and excluding features for each; osteosarcoma prioritised with clear, multi-feature justification referencing both clinical and radiologic data. |
| Radiologic-Pathologic Correlation -- Assesses the student's ability to link radiologic signs to underlying tissue processes (PA32.7 bone morphology; PA32.1 tumour behaviour), the central skill in bone pathology | 6 pts | All three radiologic signs (Codman triangle, sunburst pattern, lytic-sclerotic mixed pattern) correctly explained at the tissue level with precise pathological language; MRI soft-tissue component correctly interpreted as cortical breakthrough and extraosseous extension signifying high-grade behaviour. |
| Gross & Microscopic Pathology -- Assesses accurate description of expected morphology (PA32.1, PA32.7), including correct identification of the conventional osteoblastic subtype and its defining H&E criterion (malignant osteoid production by tumour cells) | 6 pts | Gross description accurate (gritty, grey-white, haemorrhagic cut surface; cortical destruction; soft-tissue extension); H&E description names pleomorphic spindle/polygonal cells producing malignant osteoid directly, with mitoses and vascular invasion; conventional osteoblastic subtype correctly identified; appropriate ancillary stain named with expected result (e.g. SATB2 nuclear positivity). |
| Pathogenesis & Molecular Basis -- Assesses depth of understanding of tumour biology (PA32.1): cell of origin, site predilection, tumour-suppressor pathway disruption, and alkaline phosphatase significance | 6 pts | Cell of origin (osteoblast precursor / primitive mesenchymal cell) identified; metaphyseal site explained via rapid bone turnover at growth plate; at least two tumour suppressors named with chromosomal loci (RB1 at 13q14; TP53 at 17p13); cell-cycle disruption explained (loss of G1-S checkpoint); ALP elevated as marker of osteoblastic activity used for treatment response monitoring. |
| Investigations, Staging & Prognosis -- Assesses ability to order and interpret targeted investigations, apply a staging system, and discuss Huvos grading as a pathologist-specific prognostic tool (PA32.1, PA32.3 integrated) | 7 pts | Investigations include: CT thorax (pulmonary metastases), bone scan or PET-CT (skip lesions, systemic disease), serum ALP and LDH (tumour burden/monitoring), and core needle biopsy for histology; each linked to a specific clinical question. Enneking staging correctly applied (Stage IIB: high-grade, extracompartmental, no metastasis -- justification matches vignette). Huvos Grade III (>90% necrosis, 5-year survival ~75%) and Grade IV (100% necrosis) defined accurately; significance of clear CXR and at least two adverse histopathological prognostic features (e.g. vascular invasion, skip metastases, low Huvos grade) discussed. Concluding sentence on MDT role is apt. |
PEER REVIEW
You will review TWO classmates' submissions using the rubric above. For each submission:
- Read the entire submission before scoring any criterion -- overall coherence matters.
- Score each of the five criteria independently using the rating descriptors. Select the rating level that BEST matches the submission; do not interpolate between levels.
- For EVERY criterion, write a minimum of two sentences of qualitative feedback: one sentence identifying what the author did well and one sentence identifying a specific gap or error with a suggestion for improvement. Vague comments ('good work' or 'needs improvement') are not acceptable.
- After scoring all criteria, write an overall comment (3-5 sentences) noting: (a) the strongest section of the submission, (b) the most important conceptual gap, and (c) one concrete suggestion the author can act on for their next pathology case study.
- Be respectful and constructive. Your feedback is visible to the author and the faculty.
- Peer review quality is assessed by the faculty; inaccurate scoring (>4 points off the faculty score on any criterion) may be flagged for discussion.
- Complete both reviews before the peer-review deadline. Incomplete peer review results in a 5-point deduction from your own assignment score.